1
Hartung Ingo, Kettschau Georg, Schumann Ingrid, Thierauch Karl Heinz, Boemer Ulf: 3-h-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same. Bayer Schering Pharma Aktiengesellschaft, Hartung Ingo, Kettschau Georg, Schumann Ingrid, Thierauch Karl Heinz, Boemer Ulf, June 19, 2008: WO/2008/071456 (16 worldwide citation)

The invention relates to 3-H-pyrazolopyridines according to the general formula (I) in which A, B, D, E, Ra, R1, R2, R3, R4, R5 and q are as defined in the claims, and salts, N-oxides, solvates and prodrugs thereof, to pharmaceutical compositions comprising said 3-H-pyrazolopyridine compounds, to me ...


2
Nguyen Duy, Mengel Anne, Fritsch Martin, Langer Gernot, Boemer Ulf, Khim Seock Kyu, Eis Knut, Menzenbach Bernd, Buchmann Bernd: (De) Indol derivative als inhibitoren der löslichen adenylatzyklase, (En) Indol derivatives as inhibitors of soluble adenylyl cyclase. Bayer Schering Pharma Aktiengesellschaft, March 30, 2006: WO/2006/032541 (9 worldwide citation)

(EN) The invention relates to compounds of general formula (I), to the production thereof, and to the use of the same as medicaments.(DE) Die Erfindung betrifft Verbindungen der allgemeinen Formel (I) sowie deren Herstellung und Verwendung als Medikament.


3
Hartung Ingo, Bothe Ulrich, Kettschau Georg, Luecking Ulrich, Mengel Anne, Krueger Martin, Thierauch Karl Heinz, Lienau Philip, Boemer Ulf: Alkynylpyrimidines as tie2 kinase inhibitors. Bayer Schering Pharma Aktiengesellschaft, Hartung Ingo, Bothe Ulrich, Kettschau Georg, Luecking Ulrich, Mengel Anne, Krueger Martin, Thierauch Karl Heinz, Lienau Philip, Boemer Ulf, December 24, 2008: WO/2008/155140 (7 worldwide citation)

The invention relates to alkynylpyrimidines according to the general formula (I) in which A, R1, R2, R3, R4, R5, and R6 are as defined in the claims, to pharmaceutical compositions comprising said alkynylpyrimidines, to methods of preparing said alkynylpyrimidines, as well as to uses thereof for man ...


4

5
LUECKING ULRICH, BOHLMANN ROLF, SCHOLZ ARNE, SIEMEISTER GERHARD, GNOTH MARK, BOEMER ULF, RUEHTER GERD, SCHULTZ FADEMRECHT CARSTEN: 4-Aryl-N-phényl-1,3,5-triazin-2-amines portant un groupe sulfoximine en tant quinhibiteurs de CDK9, 4-Aryl-N-Phenyl-1,3,5-Triazin-2-Amine mit einer Sulfoximingruppe als CDK9-Hemmer, 4-Aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group as CDK9 inhibitors. BAYER IP, November 28, 2012: EP2527332-A1 (5 worldwide citation)

The present invention relates to 4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group of general formula ( I ) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, in particular of hyper-proliferative disord ...


6
Hartung Ingo, Ince Stuart, Kettschau Georg, Thierauch Karl Heinz, Briem Hans, Boemer Ulf: Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them.. Bayer Schering Pharma, December 19, 2007: EP1867648-A1 (2 worldwide citation)

The invention relates to substituted pyrazolopyridines according to the general formula (1) : in which A, B, D, E, R a , R 1 , R 2 , R 3 , R 4 , R 5 and q are as defined in the claims, and salts thereof, to pharmaceutical compositions comprising said substituted pyrazolopyridine compounds, to method ...


7
Bothe Ulrich, Von Bonin Arne, Nguyen Duy, Boemer Ulf, Guenther Judith: New 2 hetarylthiazol-4-carboxylic acid derivatives, their manufacture and use as medicine. Bayer Schering Pharma, June 17, 2009: EP2070924-A1 (1 worldwide citation)

2-Hetaryl thiazole-4-carboxamide derivatives (I) with the building blocks A, B, C and D, and their salts, enantiomers or diastereomers, are new. 2-Hetaryl thiazole-4-carboxamide derivatives of formula (I) with the building blocks A, B, C and D, and their salts, enantiomers or diastereomers, are new. ...


8

9

10
Hartung Ingo, Kettschau Georg, Briem Hans, Luecking Ulrich, Schaefer Martina, Lienau Philip, Boemer Ulf, Thierauch Karl Heinz: Sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same. Bayer Schering Pharma Aktiengesellschaft, Hartung Ingo, Kettschau Georg, Briem Hans, Luecking Ulrich, Schaefer Martina, Lienau Philip, Boemer Ulf, Thierauch Karl Heinz, December 27, 2007: WO/2007/147574 (1 worldwide citation)

The invention relates to sulfonamido-macrocycles according to the general formula (I): in which R1, R2, R4, R5, R6, A, B, C, L, X, Y, Z, n, and m are as defined in the claims, and salts, N-oxides, or solvates thereof, to pharmaceutical compositions comprising said sulfonamido-macrocycles, to methods ...